Antitrypsin Deficiency (AATD) Augmentation Therapy Market Rising in United States | Fortune Business Insights

 The global alpha-1 antitrypsin deficiency augmentation therapy market has been boosted by recent FDA approval for Prolastin-C. According to a report published by Fortune Business Insights, titled “AATD Augmentation Therapy: Global Analysis, Insights and Forecast, 2019-2026”, the market will be valued at US$ 1959.8 Mn by the end of 2025. The estimated rise in market value from its 2017 value of US$ 1115.5 Mn implies that the market will exhibit a CAGR of 5.9% in the forecast period. Fortune Business Insights expects that factors such as regulatory approvals and improvements in augmentation therapies will drive the market in this period.

Get Sample PDF Brochure:

Prolastin C to Emerge as the Leading Product Type  

Prolastin C manufactured by Grifols, S.A. is considered as the most widely used product in augmentation therapy for AATD. In terms of value, Prolastin C accounted for 63.1% share in the market in 2018. The product is expected to maintain dominance through the forecast period. Besides Prolastin C, there are some other product types that have been adopted widely. The recent approval ‘Respreeza’ in Europe and Asia has fueled its demand in these regions. In 2016, Kamada Ltd and Shire plc announced the US FDA approval of expanded label for Glassia, making it the first self-infused treatment for adults with emphysema due to severe AATD. Therefore, increasing regulatory approvals for various products are likely to boost the global AATD augmentation therapy market in the forecast period.

Market in Asia Pacific to Exhibit Highest CAGR

Active government participation in prevention and control of genetic disorders is boosting the AATD augmentation therapy market in Asia-Pacific. Furthermore, improved diagnostic techniques for critical diseases is favoring expansion of the market in Asia-Pacific. Although Asia-Pacific exhibits highest CAGR, the AATD augmentation therapy market in North America was valued at US$ 620.0 Mn in 2018, which was the highest among all regions. The AATD augmentation therapy market in North America is likely to remain dominant throughout the forecast period. North America’s dominance is attributable to the rising prevalence of AATD disorder in the U.S. and Canada, and exceptional business strategies of leading companies in the region. Europe is estimated to be the second most prominent region in terms of market value in 2018.

Quick Buy - Antitrypsin Deficiency (AATD) Augmentation Therapy Market Research Report:

Grifols SA’s AlfaCare Program Has Had a Positive Impact on the Global Market

In November 2018, Grifols Sa introduced AlfaCare, a therapy program aimed at providing training and counselling to patients diagnosed with AATD. Grifols stated that with AlfaCare, it aims to encourage new habits in AATD patients and help them manage their disease properly. Research studies have proven that a huge percentage of people diagnosed with AATD were unaware about the symptoms, effects, and ways to treat the disorder. AlfaCare was launched to overcome all such shortcomings and improve the quality of patient care, thereby ascertaining reduced fatality rate of AATD. Thus, AlfaCare has transformed AATD augmentation therapies worldwide and is likely to boost the global AATD augmentation therapy market in the forecast period.

Related Topics :

Animal Health Market

Pulse Oximeters Market

Diabetes Devices Market

In-vitro Diagnostics Market

mHealth Market

Ocular Implants Market 

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245



Popular posts from this blog

Laser Hair Removal Market Is Forecast To Reach USD 1619.7 Million By 2028

Bone Growth Stimulator Market Rising in United States | Market Future Size

Advanced wound care market in Europe and North America | Emerging Technologies, Future Scope